Pericor Science

Pericor Science is a biotechnology company dedicated to the discovery and development of innovative treatments for cardiovascular diseases, specifically heart failure. The company's primary focus is on the development of small molecule inhibitors of Phosphodiesterase 9 (PDE9), an enzyme that plays a critical role in regulating cyclic GMP levels in the heart. By targeting this pathway, Pericor aims to provide new therapeutic options for patients suffering from heart failure with preserved ejection fraction (HFpEF), a condition currently lacking effective treatments. The company's technology is based on foundational research conducted at Johns Hopkins University. Pericor Science continues to advance its pipeline through rigorous preclinical testing and strategic development efforts.